Effect of 12 Months Treatment With rhPTH on Calcium Balance, Bone Turnover, Bone Mineral Density, and Bone Micro-architecture in Patients With Fractures Associated With Low Bone Turnover and Sclerosing Bone Disorders
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Pharmacodynamics
- 28 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Oct 2007 The expected completion date for this trial is now 1 Jul 2010.
- 26 Nov 2005 New trial record.